Distinguished in Anemia

Dr. Eric J. Avery

Hematology Oncology | Oncology | Hematology
Nebraska Hematology-Oncology PC
4004 Pioneer Woods Dr, 
Lincoln, NE 
Accepting New Patients
Offers Telehealth
Distinguished in Anemia
Nebraska Hematology-Oncology PC
4004 Pioneer Woods Dr, 
Lincoln, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Avery is a Hematologist Oncology specialist and an Oncologist in Lincoln, Nebraska. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Chronic B-Cell Leukemia (CBCL). Dr. Avery is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Hematology
Licenses
Internal Medicine in NE
Hospital Affiliations
York General Health Care Services
Bryan Medical Center
Fillmore County Hospital
Memorial Health Care Systems
The Nebraska Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

NEBRASKA HEMATOLOGY-ONCOLOGY PC
4004 Pioneer Woods Dr, Lincoln, NE 68506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

6 Total Publications

Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.
Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.
Journal: HemaSphere
Published: July 07, 2022
Similar Doctors
Distinguished in Anemia
Dr. Wallace C. Peterson
Hematology Oncology | Hematology | Oncology
Distinguished in Anemia
Dr. Wallace C. Peterson
Hematology Oncology | Hematology | Oncology

Cancer Partners Of Nebraska PC

201 S 68th St Pl, Suite 200, 
Lincoln, NE 
 (2.7 miles away)
402-420-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Wallace Peterson is a Hematologist Oncology specialist and a Hematologist in Lincoln, Nebraska. Dr. Peterson is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Colorectal Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Peterson is currently accepting new patients.

Distinguished in Anemia
Dr. Madhu V. Midathada
Hematology Oncology | Oncology | Hematology
Distinguished in Anemia
Dr. Madhu V. Midathada
Hematology Oncology | Oncology | Hematology

Nebraska Hematology-Oncology PC

4004 Pioneer Woods Dr, 
Lincoln, NE 
 (0.1 miles away)
402-484-4900
Languages Spoken:
English, Hindi, Telugu
See accepted insurances
Accepting New Patients

Madhu Midathada is a Hematologist Oncology specialist and an Oncologist in Lincoln, Nebraska. Dr. Midathada is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Paget Disease of the Breast, Multiple Myeloma, Lung Cancer, Severe Congenital Neutropenia, and Bone Marrow Aspiration. Dr. Midathada is currently accepting new patients.

Distinguished in Anemia
Dr. Robert M. Langdon
Hematology Oncology | Oncology | Hematology
Distinguished in Anemia
Dr. Robert M. Langdon
Hematology Oncology | Oncology | Hematology

Oncology Hematology West, PC

7500 Mercy Rd, Suite 1300, 
Omaha, NE 
 (44.7 miles away)
402-393-3110
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Langdon is a Hematologist Oncology specialist and an Oncologist in Omaha, Nebraska. Dr. Langdon is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Langdon is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Avery's expertise for a condition
ConditionClose
    View All 19 Distinguished Conditions
    View All 66 Advanced Conditions
    View All 166 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile